In aggregates, these results suggest a critical role of astrocytic NEO1-loss in the development of a moyamoya disease-like vasculopathy, providing a mouse model for investigating mechanisms of a moyamoya disease-like vasculopathy (195). This evidence concerns the gene NEO1 and Moyamoya disease.